Trials / Terminated
TerminatedNCT03943823
Postmenopausal Pessary Users: Estrogen Versus Trimosan
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- The University of Texas Health Science Center, Houston · Academic / Other
- Sex
- Female
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare vaginally applied estrogen with the vaginal gel trimosan for their effects on vaginal pH and vaginal symptoms in postmenopausal pessary users.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Estrogen vaginal cream | Either Premarin or Estrace cream will be used (dependent on patient's insurance). Premarin 1 gram every night for the first 7 days, then 0.5 grams twice weekly. Estrace cream 2 grams daily for first 7 days, then 1 gram twice-weekly. |
| DRUG | Trimo-San vaginal gel | Half applicator for three times a week for 1st week, then half applicator for 2 times a week. |
Timeline
- Start date
- 2019-05-07
- Primary completion
- 2021-03-08
- Completion
- 2021-04-08
- First posted
- 2019-05-09
- Last updated
- 2023-03-08
- Results posted
- 2023-03-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03943823. Inclusion in this directory is not an endorsement.